# Study for Treatment of Chronic Diabetic Foot Ulcers With the Investigational Allogeneic Cell Therapy Product, hOMSC200

> **NCT06003530** · PHASE1 · UNKNOWN · sponsor: **Cytora Ltd.** · enrollment: 21 (actual)

## Conditions studied

- Diabetic Foot
- Diabetic Foot Ulcer
- Diabetic Foot Ulcer Neuropathic

## Interventions

- **BIOLOGICAL:** hOMSC200
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06003530
- **Lead sponsor:** Cytora Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-06
- **Primary completion:** 2023-12-19
- **Final completion:** 2024-12-31
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2024-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06003530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06003530, "Study for Treatment of Chronic Diabetic Foot Ulcers With the Investigational Allogeneic Cell Therapy Product, hOMSC200". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06003530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*